[THERAPEUTIC EXPERIENCES WITH RESOCHIN AND RESOCHIN-CONTAINING PREPARATIONS IN DERMATOLOGICAL PATIENTS].
D002294:Carcinoma, Squamous Cell; D002738:Chloroquine / Q000031:analogs & derivatives; D003875:Drug Eruptions; D004358:Drug Therapy; D005383:Finger Injuries; D006406:Hematoma; D006561:Herpes Simplex; D006801:Humans; D007642:Keratosis; D007918:Leprosy; D008010:Lichen Planus; D008179:Lupus Erythematosus, Discoid; D008180:Lupus Erythematosus, Systemic; D009182:Mycosis Fungoides; D009335:Necrobiosis Lipoidica; D010392:Pemphigus; D010787:Photosensitivity Disorders; D011164:Porphyrias; D011536:Prurigo; D012595:Scleroderma, Systemic; D012871:Skin Diseases; D012878:Skin Neoplasms; D014983:Xeroderma Pigmentosum
C023676:chloroquine diphosphate; D002738:Chloroquine
CARCINOMA, EPIDERMOID; CHLOROQUINE; DERMATITIS MEDICAMENTOSA; DRUG THERAPY; FINGER INJURIES; HEMATOMA; HERPES SIMPLEX; KERATOSIS; LEPROSY; LICHEN PLANUS; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOSIS FUNGOIDES; NECROBIOSIS LIPOIDICA; PEMPHIGUS; PHOTOSENSITIZATION; PORPHYRIA; PRURIGO; SCLERODERMA; SKIN DISEASES; SKIN NEOPLASMS; XERODERMA PIGMENTOSUM
THERAPEUTISCHE ERFAHRUNGEN MIT RESOCHIN UND RESOCHINHALTIGEN PRAEPARATEN BEI DERMATOLOGISCHEM KRANKENGUT.